[1] Deshmukh S, Prashanth S.Ectodermal dysplasia: a genetic review[J]. Int J Clin Pediatr Dent, 2015, 5(3): 197-202. [2] Trzeciak WH, Koczorowski R.Molecular basis of hypohidrotic ectodermal dysplasia: an update[J]. J Appl Genet, 2016, 57(1): 51-61. [3] Pagnan NA, Visinoni ÁF.Update on ectodermal dysplasias clinical classification[J]. Am J Med Genet A, 2014, 164A(10): 2415-2423. [4] Machado M, Wallace C, Austin B, et al.Rehabilitation of ectodermal dysplasia patients presenting with hypodontia: outcomes of implant rehabilitation part 1[J]. J Prosthodont Res, 2018, 62(4): 473-478. [5] Wang Y, He J, Decker AM, et al.Clinical outcomes of implant therapy in ectodermal dysplasia patients: a systematic review[J]. Int J Oral Maxillofac Surg, 2016, 45(8): 1035-1043. [6] Ngoc VTN, Duong NT, Chu DT, et al.Clinical, radiographic, and genetic characteristics of hypohidrotic ectodermal dysplasia: A cross-sectional study[J]. Clin Genet, 2018, 94(5): 484-486. [7] Yohe S, Thyagarajan B.Review of clinical next-generation sequencing[J]. Arch Pathol Lab Med, 2017, 141(11): 1544-1557. [8] Wen M, Shen T, Wang Y, et al.Next-generation sequencing in early diagnosis of dent disease 1: two case reports[J]. Front Med (Lausanne), 2018, 5: 347. [9] Kuo FC.Next generation sequencing in hematolymphoid neoplasia[J]. Semin Hematol, 2019, 56(1): 2-6. [10] Wei Y, Shen K, Lv T, et al.Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis[J]. Lung Cancer, 2018, 125: 43-50. [11] Liu H, Naismith JH.An effcient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol[J]. BMC Biotechnol, 2008, 8: 91. [12] Patthey C, Gunhaga L.Signaling pathways regulating ectodermal cell fate choices[J]. Exp Cell Res, 2014, 321(1): 11-16. [13] Deshmukh S, Prashanth S.Ectodermal dysplasia: a genetic review[J]. Int J Clin Pediatr Dent, 2012, 5(3): 197-202. [14] Cluzeau C, Hadj-Rabia S, Jambou M, et al.Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases[J]. Hum Mutat, 2011, 32(1): 70-72. [15] Schneider P, Street SL, Gaide O, et al.Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functionaldomains in the tumor necrosis factor family member ectodysplasin-A[J]. J Biol Chem, 2001, 276(22): 18819-18827. [16] Yan M, Wang LC, Hymowitz SG, et al.Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors[J]. Science, 2000, 290(5491): 523-527. [17] Lefebvre S, Mikkola ML.Ectodysplasin research-where to next?[J]. Semin Immunol, 2014, 26(3): 220-228. [18] Krφigård AB, Clemmensen O, Gjφrup H, et al.Odonto-onycho-dermal dysplasia in a patient homozygous for a WNT10A nonsense mutation and mild manifestations of ectodermal dysplasia in carriers of the mutation[J]. BMC Dermatol, 2016, 16: 3. [19] Guazzarotti L, Tadini G, Mancini GE, et al.WNT10A gene is the second molecular candidate in a cohort of young Italian subjects with ectodermal derivative impairment (EDI)[J]. Clin Genet, 2018, 93(3): 693-698. [20] Döffinger R, Smahi A, Bessia C, et al.X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling[J]. Nat Genet, 2001, 27(3): 277-285. [21] Arzoo PS, Klar J, Bergendal B, et al.WNT10A mutations account for 1/4 of population-based isolated oligodontia and show phenotypic correlations[J]. Am J Med Genet A, 2014, 164A(2): 353-359. |